Indeed, in various tumor types, such as glioma, colon cancer, pancreatic cancer, and liver cancer, CD133(+) cells consistently display characteristics resembling those of stem cells (32), underscoring the potential significance of CD133 as a marker for tumor stem cells. This evidence concerns the gene PROM1 and neoplasm.